ArticleCancer biotherapy & radiopharmaceuticals2020

The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway.

Massimo Fantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.